Research Review

Act ACCORDingly: Rein in Blood Sugar, Reduce Retinopathy Risk

Can short-term tight glycemic control stem disease progression for a lifetime? A new study offers encouragement.
06/29/2016

Pediatric Myopia: These Genes Don’t Fit

Close reading increases the likelihood of refractive error in children with variations in a particular gene. But does it matter?
09/21/2015

Finally, a Consensus on Keratoconus?

Experts gathered to discuss the diagnosis and management of keratoconus and ectatic diseases. Here’s what they agreed upon—and what they missed.
04/01/2015

Eylea Outperforms Other Anti-VEGFs for Some DME Patients

An NIH study documents its superiority when initial visual acuity is poor. Here’s what comanaging ODs need to know.
03/20/2015

Fuchs’ Endothelial Corneal Dystrophy—Up Close and Personal

In vivo confocal microscopy offers an unprecedented look into the disease process, which could help clinicians identify at-risk patients and improve outcomes.
03/04/2015

VEGF Trap-eye Snares DME

Eylea provides a longer duration of effect for diabetic macular edema patients than other anti-VEGF options.
11/15/2014

Look What the CATT Dragged In

For anti-VEGF treatment of AMD, monthly frequency and ranibizumab treatment were associated with a higher risk of geographic atrophy.
10/15/2014

Is Damage Still Occurring?

Can Plaquenil macular toxicity continue to progress long after the patient stops taking the drug?
09/15/2014